Appili Therapeutics Announces Over Us$10 Million In New Funding From Us Department Of Defense For Biodefense Vaccine Candidate Ati-1701
Amount Raised
$10 Million
Round Type
Funding Round
HalifaxBiotechnologyHealth CareScience And EngineeringDescription
Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, today announced that the U.S. Department of Defense (“DOD”), via the Joint Science and Technology Office of the Defense Threat Reduction Agency (“DTRA”), has selected for funding an Appili proposal that would provide over US$10 million to advance the Company’s biodefense vaccine candidate ATI-1701, a potential first-in-class vaccine candidate for the prevention of infection with Francisella tularensis, the causative agent of tularemia and a top-priority biothreat.
Quick answer
Appili Therapeutics Inc. raised $10 Million in a Funding Round round, dated February 28, 2022. Appili Therapeutics Inc. is based in Halifax, England, United Kingdom.
- How much did Appili Therapeutics Inc. raise?
- Appili Therapeutics Inc. raised $10 Million in a Funding Round round on February 28, 2022.
- What does Appili Therapeutics Inc. do?
- Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections.
- Where is Appili Therapeutics Inc. based and how big is it?
- Appili Therapeutics Inc. is based in Halifax, England, United Kingdom.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Appili Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.
- Surf Bio raised $16M (Seed) on April 12, 2022.
- Trait Biosciences Inc. raised $210K (Series A) on April 6, 2022.
- Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
- Ray Therapeutics raised $6M on April 5, 2022.
- Zephyr AI, Inc. raised $18M on April 4, 2022.
- 2seventy bio raised $170M on March 31, 2022.
Who to call at Appili Therapeutics Inc., and when
A new round usually means Appili Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Appili Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Appili Therapeutics Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Appili Therapeutics Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Appili Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Appili Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.